Testing effectiveness (Phase 2)Active Not RecruitingNCT05164094
What this trial is testing
An Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
Who this might be right for
Epstein-Barr Virus Infection
ModernaTX, Inc. 867